We employed ROC curve analyses to determine the optimal cut-off values of TPS for PD-L1 expression and stromal CD8 + TIL density in prediction of death or tumour recurrence, which may not be suitable for the present study with a small number of patients. The gene discussed is CD8A; the disease is neoplasm.